Related Experiment Video
Updated: May 28, 2026
12:40
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
Development of a highly sensitive method for detection of JAK2V617F
Anna H Zhao1, Rufei Gao, Zhizhuang J Zhao
1Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA.
Journal of Hematology & Oncology
|October 12, 2011
Summary
A new highly sensitive method, restriction fragment nested allele-specific PCR (RFN-AS-PCR), can detect the JAK2V617F mutation in myeloproliferative neoplasms (MPNs). This advancement aids in the early diagnosis and prevention of MPNs.
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Background:
- Myeloproliferative neoplasms (MPNs) are clonal hematopoietic stem cell disorders.
- The JAK2V617F mutation is a key driver in the majority of MPNs.
- Current diagnostic methods for JAK2V617F require enhanced sensitivity for early detection.
Purpose of the Study:
- To develop a highly sensitive method for detecting the JAK2V617F mutation.
- To improve early diagnosis and potential prevention strategies for MPNs.
Main Methods:
- Developed restriction fragment nested allele-specific PCR (RFN-AS-PCR).
- Method involves initial PCR amplification, BsaXI restriction enzyme digestion of wild-type alleles, and allele-specific nested PCR for JAK2V617F detection.
Main Results:
- RFN-AS-PCR achieved a sensitivity of 0.001% for JAK2V617F detection.
- Identified three JAK2V617F-positive cases in 105 healthy donors, previously undetectable.
Conclusions:
- The developed RFN-AS-PCR method offers high sensitivity for early JAK2V617F detection.
- This method holds significant potential for the diagnosis and prevention of MPNs and related conditions.
More Related Videos
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:33Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
01:26Receptor Tyrosine Kinases
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...